Sinopharm Hyundai (600420.SH) released its 2023 annual report, achieving revenue of 12.07 billion yuan,...
According to the Zhitong Finance App, Sinopharm Hyundai (600420.SH) released its 2023 annual report, achieving revenue of 12.07 billion yuan, a year-on-year decrease of 6.86%. Achieved net profit of 692 million yuan attributable to shareholders of listed companies, an increase of 10.21% over the previous year. Achieved net profit of 683 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 23.61% over the previous year. A cash dividend of 1.00 yuan (tax included) is distributed to all shareholders for every 10 shares.